Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Genmab a::S symbols : Gsk save search
Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published: 2023-05-15 (Crawled : 17:00) - prnewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: 0.24%
H: 0.66%
C: 0.66%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.61%
H: 0.3%
C: 0.24%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.2%
H: 0.13%
C: -0.22%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.27%
H: 0.6%
C: 0.41%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 0.38%
H: 0.91%
C: 0.69%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.14%
H: 0.28%
C: 0.11%
report cancer global therapy growth market
Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
Published: 2022-11-04 (Crawled : 18:00) - prnewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: -2.57%
H: 3.43%
C: 2.04%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.13%
H: 0.63%
C: 0.53%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.25%
H: 0.03%
C: -0.78%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.97%
H: 0.18%
C: -2.13%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.42%
H: 0.59%
C: -0.04%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.64%
H: 0.16%
C: -0.05%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 0.58%
H: 0.93%
C: 0.93%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -1.48%
H: 2.81%
C: 2.71%
report cancer market
Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others
Published: 2022-04-28 (Crawled : 21:00) - prnewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: 2.93%
H: 1.47%
C: 1.33%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: -0.99%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.19%
H: 0.59%
C: -1.36%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -3.61%
H: 3.02%
C: 2.02%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 1.4%
H: 0.82%
C: -1.07%
t-cell
Hematological Malignancies Drugs Market worth $ 42.78 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-08 (Crawled : 11:00) - prnewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: -0.14%
H: 5.36%
C: 5.36%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -2.75%
H: 0.28%
C: -1.04%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.38%
H: 1.81%
C: 0.28%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -1.55%
H: 0.71%
C: -0.28%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 1.4%
H: 0.7%
C: -1.15%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: -0.3%
H: 3.38%
C: 0.32%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
ema drug report
Worldwide Drug Delivery Industry to 2027 - Growing Focus Towards Home Care and Self-Administration Presents Opportunities
Published: 2022-02-23 (Crawled : 18:00) - prnewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: 5.23%
H: 0.0%
C: -0.34%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.48%
H: 3.79%
C: 3.12%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: -1.1%
WST | $377.33 -0.01% 0.0% 320K
|
Health Technology
|
| O: 0.24%
H: 0.24%
C: -3.38%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.82%
H: 0.07%
C: -1.0%
MDT | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: 0.5%
H: 0.25%
C: -1.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.23%
H: 0.7%
C: -0.18%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.9%
H: 0.07%
C: -0.87%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.59%
H: 0.89%
C: -0.93%
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: 0.22%
H: 1.9%
C: 1.48%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.45%
H: 1.46%
C: 0.37%
MMM | $91.48 0.57% 0.0% 3M
|
Producer Manufacturing
|
| O: 0.0%
H: 0.4%
C: -1.61%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.09%
H: 0.08%
C: -1.22%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: -1.67%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: -1.85%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.29%
H: 0.87%
C: -2.6%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.57%
H: 0.48%
C: -0.75%
drug liver growing drug delivery
CureVac Appoints Klaus Edvardsen as Chief Development Officer
Published: 2021-06-02 (Crawled : 12:00) - biospace.com/
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.13%
H: 0.44%
C: -0.03%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 0.0%
H: 1.04%
C: 0.95%
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: -0.26%
H: 6.12%
C: 6.12%
Global Acute Lymphoblastic Leukemia Treatment Market Research Report (2020 to 2025) - by Types of Cell, Therapy and Region
Published: 2021-03-24 (Crawled : 17:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.36%
H: 0.36%
C: -0.21%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.86%
H: 1.01%
C: 0.53%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 0.95%
H: 0.91%
C: -9.38%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.25%
H: 0.39%
C: 0.27%
JAZZ | $109.3 2.05% 2.01% 560K
|
Health Technology
|
| O: 0.54%
H: 1.24%
C: -0.9%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -0.22%
H: 1.09%
C: -0.02%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: -2.59%
TECH | $62.25 -0.77% -0.77% 1.2M
|
Health Technology
|
| O: 0.32%
H: 1.09%
C: -2.18%
treatment therapy leukemia research
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.